ID

19548

Description

Sirolimus (Rapamune®) for Autosomal Dominant Polycystic Kidney Disease (ADPKD); ODM derived from: https://clinicaltrials.gov/show/NCT00346918

Link

https://clinicaltrials.gov/show/NCT00346918

Keywords

Versions (1)
  1. 1/9/17 1/9/17 -
Uploaded on

January 9, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Autosomal Dominant Polycystic Kidney Disease (ADPKD) NCT00346918

English

Eligibility Autosomal Dominant Polycystic Kidney Disease (ADPKD) NCT00346918

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
male or female adpkd patient between 18 and 40 years of age
Description

Polycystic Kidney, Autosomal Dominant | Age

Data type

boolean

Alias
UMLS CUI [1]
C0085413
UMLS CUI [2]
C0001779
measured gfr higher than 70 ml/min 1.73m2
Description

Glomerular Filtration Rate

Data type

boolean

Alias
UMLS CUI [1]
C0017654
documented kidney volume progression
Description

Kidney Volume Progressive

Data type

boolean

Alias
UMLS CUI [1,1]
C2827452
UMLS CUI [1,2]
C0205329
informed consent
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
female of childbearing potential who is planning to become pregnant, who is pregnant and/or lactating, who is unwilling to use effective means of contraception
Description

Childbearing Potential Planned Pregnancy | Pregnancy | Breast Feeding | Childbearing Potential Contraceptive methods Unwilling

Data type

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0032992
UMLS CUI [2]
C0032961
UMLS CUI [3]
C0006147
UMLS CUI [4,1]
C3831118
UMLS CUI [4,2]
C0700589
UMLS CUI [4,3]
C0558080
increased liver enzymes (2-fold above normal values)
Description

Elevated liver enzymes

Data type

boolean

Alias
UMLS CUI [1]
C0235996
hypercholesterolemia (fasting cholesterol > 8 mmol/l) or hypertriglyceridaemia (> 5 mmol/l) not controlled by lipid lowering therapy
Description

Hypercholesterolemia Uncontrolled | Fasting cholesterol level | Hypertriglyceridemia Uncontrolled | Lipid-lowering therapy

Data type

boolean

Alias
UMLS CUI [1,1]
C0020443
UMLS CUI [1,2]
C0205318
UMLS CUI [2]
C1282513
UMLS CUI [3,1]
C0020557
UMLS CUI [3,2]
C0205318
UMLS CUI [4]
C0585943
granulocytopenia (white blood cell < 3,000/mm3) or thrombocytopenia (platelets < 100,000/mm3),
Description

Agranulocytosis | White Blood Cell Count procedure | Thrombocytopenia | Platelet Count measurement

Data type

boolean

Alias
UMLS CUI [1]
C0001824
UMLS CUI [2]
C0023508
UMLS CUI [3]
C0040034
UMLS CUI [4]
C0032181
infection with hepatitis b or c, hiv
Description

Hepatitis B | Hepatitis C | HIV Infection

Data type

boolean

Alias
UMLS CUI [1]
C0019163
UMLS CUI [2]
C0019196
UMLS CUI [3]
C0019693
any past or present malignancy
Description

Malignant Neoplasms

Data type

boolean

Alias
UMLS CUI [1]
C0006826
mental illness that interfere with the patient ability to comply with the protocol
Description

Mental disorder Interferes with Protocol Compliance

Data type

boolean

Alias
UMLS CUI [1,1]
C0004936
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C0525058
drug or alcohol abuse within one year of baseline
Description

Substance Use Disorders

Data type

boolean

Alias
UMLS CUI [1]
C0038586
co-medication with strong inhibitor of cyp3a4 and or p-gp like voriconazole, ketoconazole, diltiazem, verapamil, erythromycin
Description

Cytochrome P450 3A4 Inhibitor Strong | P-Glycoprotein Similarity | Voriconazole | Ketoconazole | Diltiazem | Verapamil | Erythromycin

Data type

boolean

Alias
UMLS CUI [1,1]
C3830624
UMLS CUI [1,2]
C0442821
UMLS CUI [2,1]
C0242643
UMLS CUI [2,2]
C2348205
UMLS CUI [3]
C0393080
UMLS CUI [4]
C0022625
UMLS CUI [5]
C0012373
UMLS CUI [6]
C0042523
UMLS CUI [7]
C0014806
co-medication with strong cyp3a4 and or p-gp inductor like rifampicin
Description

Cytochrome P-450 CYP3A4 Strong | P-Glycoprotein Inducer Similarity | Rifampin

Data type

boolean

Alias
UMLS CUI [1,1]
C3714798
UMLS CUI [1,2]
C0442821
UMLS CUI [2,1]
C0242643
UMLS CUI [2,2]
C3898767
UMLS CUI [2,3]
C2348205
UMLS CUI [3]
C0035608
known hypersensitivity to macrolides or rapamune
Description

Macrolide allergy | Hypersensitivity Rapamune

Data type

boolean

Alias
UMLS CUI [1]
C0571383
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0813828
Back to the top of the page

Similar models

Eligibility Autosomal Dominant Polycystic Kidney Disease (ADPKD) NCT00346918

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Polycystic Kidney, Autosomal Dominant | Age
Item
male or female adpkd patient between 18 and 40 years of age
boolean
C0085413 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Glomerular Filtration Rate
Item
measured gfr higher than 70 ml/min 1.73m2
boolean
C0017654 (UMLS CUI [1])
Kidney Volume Progressive
Item
documented kidney volume progression
boolean
C2827452 (UMLS CUI [1,1])
C0205329 (UMLS CUI [1,2])
Informed Consent
Item
informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Childbearing Potential Planned Pregnancy | Pregnancy | Breast Feeding | Childbearing Potential Contraceptive methods Unwilling
Item
female of childbearing potential who is planning to become pregnant, who is pregnant and/or lactating, who is unwilling to use effective means of contraception
boolean
C3831118 (UMLS CUI [1,1])
C0032992 (UMLS CUI [1,2])
C0032961 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
C3831118 (UMLS CUI [4,1])
C0700589 (UMLS CUI [4,2])
C0558080 (UMLS CUI [4,3])
Elevated liver enzymes
Item
increased liver enzymes (2-fold above normal values)
boolean
C0235996 (UMLS CUI [1])
Hypercholesterolemia Uncontrolled | Fasting cholesterol level | Hypertriglyceridemia Uncontrolled | Lipid-lowering therapy
Item
hypercholesterolemia (fasting cholesterol > 8 mmol/l) or hypertriglyceridaemia (> 5 mmol/l) not controlled by lipid lowering therapy
boolean
C0020443 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C1282513 (UMLS CUI [2])
C0020557 (UMLS CUI [3,1])
C0205318 (UMLS CUI [3,2])
C0585943 (UMLS CUI [4])
Agranulocytosis | White Blood Cell Count procedure | Thrombocytopenia | Platelet Count measurement
Item
granulocytopenia (white blood cell < 3,000/mm3) or thrombocytopenia (platelets < 100,000/mm3),
boolean
C0001824 (UMLS CUI [1])
C0023508 (UMLS CUI [2])
C0040034 (UMLS CUI [3])
C0032181 (UMLS CUI [4])
Hepatitis B | Hepatitis C | HIV Infection
Item
infection with hepatitis b or c, hiv
boolean
C0019163 (UMLS CUI [1])
C0019196 (UMLS CUI [2])
C0019693 (UMLS CUI [3])
Malignant Neoplasms
Item
any past or present malignancy
boolean
C0006826 (UMLS CUI [1])
Mental disorder Interferes with Protocol Compliance
Item
mental illness that interfere with the patient ability to comply with the protocol
boolean
C0004936 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0525058 (UMLS CUI [1,3])
Substance Use Disorders
Item
drug or alcohol abuse within one year of baseline
boolean
C0038586 (UMLS CUI [1])
Cytochrome P450 3A4 Inhibitor Strong | P-Glycoprotein Similarity | Voriconazole | Ketoconazole | Diltiazem | Verapamil | Erythromycin
Item
co-medication with strong inhibitor of cyp3a4 and or p-gp like voriconazole, ketoconazole, diltiazem, verapamil, erythromycin
boolean
C3830624 (UMLS CUI [1,1])
C0442821 (UMLS CUI [1,2])
C0242643 (UMLS CUI [2,1])
C2348205 (UMLS CUI [2,2])
C0393080 (UMLS CUI [3])
C0022625 (UMLS CUI [4])
C0012373 (UMLS CUI [5])
C0042523 (UMLS CUI [6])
C0014806 (UMLS CUI [7])
Cytochrome P-450 CYP3A4 Strong | P-Glycoprotein Inducer Similarity | Rifampin
Item
co-medication with strong cyp3a4 and or p-gp inductor like rifampicin
boolean
C3714798 (UMLS CUI [1,1])
C0442821 (UMLS CUI [1,2])
C0242643 (UMLS CUI [2,1])
C3898767 (UMLS CUI [2,2])
C2348205 (UMLS CUI [2,3])
C0035608 (UMLS CUI [3])
Macrolide allergy | Hypersensitivity Rapamune
Item
known hypersensitivity to macrolides or rapamune
boolean
C0571383 (UMLS CUI [1])
C0020517 (UMLS CUI [2,1])
C0813828 (UMLS CUI [2,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial